Skip to Content
Merck
All Photos(1)

Documents

Safety Information

SML2153

Sigma-Aldrich

TAM1 hydrochloride

≥98% (HPLC)

Synonym(s):

5-Hydroxy-4-[(4-methyl-1-piperidinyl)methyl]-2-phenyl-3-benzofurancarboxylic acid ethyl ester Hydrochloride

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C24H27NO4 · HCl
CAS Number:
1093061-14-3
Molecular Weight:
429.94
MDL number:
MFCD01847218
UNSPSC Code:
12352200
NACRES:
NA.77

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

H2O: 2 mg/mL, clear

storage temp.

2-8°C

Biochem/physiol Actions

TAM1 is an inhibitor of the thioesterase activity of Mycobacterium tuberculosis polyketide synthase Pks13. TAM1 binds to Pks13 TE domain. TAM1 exhibit a potent bactericidal activity against Mycobacterium Tuberculosis H37Rv strain.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

SML2153-25MG:
SML2153-5MG:
SML2153-BULK:
SML2153-VAR:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Thomas R Ioerger et al.
PloS one, 8(9), e75245-e75245 (2013-10-03)
Identification of new drug targets is vital for the advancement of drug discovery against Mycobacterium tuberculosis, especially given the increase of resistance worldwide to first- and second-line drugs. Because traditional target-based screening has largely proven unsuccessful for antibiotic discovery, we
Anup Aggarwal et al.
Cell, 170(2), 249-259 (2017-07-04)
Widespread resistance to first-line TB drugs is a major problem that will likely only be resolved through the development of new drugs with novel mechanisms of action. We have used structure-guided methods to develop a lead molecule that targets the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service